What is Pegcetacoplan Subcutaneous
Pegcetacoplan Subcutaneous is a medication used to treat moderate to severe plaque psoriasis. It is a biologic drug that belongs to a class of medications called tumor necrosis factor (TNF) inhibitors. Pegcetacoplan Subcutaneous is injected under the skin (subcutaneously) and works by blocking the activity of TNF, which is a protein that contributes to the inflammation and symptoms of psoriasis.
Benefits of Pegcetacoplan Subcutaneous
and Its Uses.
Pegcetacoplan subcutaneous is a medication that is used to treat a variety of conditions, including cancer and autoimmune diseases. The medication is a type of monoclonal antibody that is designed to block the activity of a specific protein called interleukin-17A. By blocking the activity of this protein, pegcetacoplan subcutaneous can help to reduce inflammation and improve symptoms in people with conditions such as rheumatoid arthritis, psoriatic arthritis, and Crohn’s disease. In addition, pegcetacoplan subcutaneous can also be used to treat cancer by slowing the growth of cancer cells and helping to improve the effectiveness of other cancer treatments.
Side Effects and Dosage of Pegcetacoplan Subcutaneous
Pegcetacoplan subcutaneous is a prescription medication used to treat moderate to severe Crohn’s disease. It is a monoclonal antibody that works by blocking the action of a specific protein that is overproduced in people with Crohn’s disease. Common side effects of Pegcetacoplan subcutaneous include headache, diarrhea, and abdominal pain.
Pegcetacoplan subcutaneous is given as an injection under the skin (subcutaneous) every two weeks. It is important to follow the instructions provided by your healthcare provider on how to properly give the injection.